A case of intravascular large B-cell lymphoma with renal involvement presenting with elevated serum ANCA titers.
Antibodies, Antineutrophil Cytoplasmic
/ blood
Antineoplastic Combined Chemotherapy Protocols
/ administration & dosage
Biopsy
Cyclophosphamide
/ administration & dosage
Doxorubicin
/ administration & dosage
Female
Humans
Injections, Spinal
Kidney
/ immunology
Kidney Glomerulus
/ immunology
Lymphoma, Large B-Cell, Diffuse
/ diagnosis
Middle Aged
Peroxidase
/ blood
Prednisone
/ administration & dosage
Proteinuria
/ diagnosis
Rituximab
/ administration & dosage
Treatment Outcome
Vascular Diseases
/ immunology
Vincristine
/ administration & dosage
Anti-neutrophil cytoplasmic antibody
Intravascular large B-cell lymphoma
Proteinuria
Renal biopsy
Journal
CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
28
03
2020
accepted:
30
07
2020
pubmed:
11
8
2020
medline:
26
10
2021
entrez:
11
8
2020
Statut:
ppublish
Résumé
We report the first case of intravascular large B-cell lymphoma (IVLBCL) presenting with vasculitis-like symptoms and elevated serum levels of anti-neutrophil cytoplasmic antibody (ANCA) diagnosed by renal biopsy. The patient exhibited low-grade fever, systemic inflammatory reactions, multiple lung lesions, and persistent proteinuria, which were closely correlated with changes in serum titers of proteinase-3- and myeloperoxidase-ANCA. Preemptive therapy with prednisolone alone partially attenuated these symptoms. Renal biopsy did not reveal histopathological findings suggestive of granulomatous or microscopic polyangiitis. Glomerular and peritubular capillaries were diffusely occluded by CD20-positive large atypical mononuclear cells, with focal foot process effacement of podocytes in the glomeruli. Based on the specific immunophenotype of infiltrated atypical cells, the patient was diagnosed with IVLBCL. Chemotherapy regimens for IVLBCL improved clinical symptoms and led to remission of proteinuria. The ANCA titers decreased in parallel with reductions in the serum levels of the soluble interleukin-2 receptor, suggestive of an association between changes in ANCA levels and IVLBCL-related vascular injuries.
Identifiants
pubmed: 32776181
doi: 10.1007/s13730-020-00515-4
pii: 10.1007/s13730-020-00515-4
pmc: PMC7829292
doi:
Substances chimiques
Antibodies, Antineutrophil Cytoplasmic
0
R-CHOP protocol
0
Rituximab
4F4X42SYQ6
Vincristine
5J49Q6B70F
Doxorubicin
80168379AG
Cyclophosphamide
8N3DW7272P
Peroxidase
EC 1.11.1.7
Prednisone
VB0R961HZT
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-63Références
Lancet. 2006 Jul 29;368(9533):404-18
pubmed: 16876669
Kidney Int Rep. 2018 Aug 08;3(6):1501-1505
pubmed: 30450479
Intern Med. 2017;56(7):827-833
pubmed: 28381751
Respiration. 2003 Jul-Aug;70(4):414-8
pubmed: 14512679
Mod Rheumatol. 2011 Apr;21(2):207-10
pubmed: 20931273
Intern Med. 2017;56(13):1715-1718
pubmed: 28674364
Hum Pathol. 1989 Mar;20(3):263-8
pubmed: 2656492
Clin Lab Haematol. 1994 Dec;16(4):363-9
pubmed: 7736714
Mod Rheumatol. 2019 Jan;29(1):195-197
pubmed: 27398728
Blood. 2018 Oct 11;132(15):1561-1567
pubmed: 30111607
Curr Rheumatol Rep. 2013 Dec;15(12):383
pubmed: 24203096
Am J Clin Pathol. 1981 Aug;76(2):183-9
pubmed: 7023227
Eur Respir J. 1997 Apr;10(4):955-7
pubmed: 9150341
Neth J Med. 2012 Jan;70(1):12-7
pubmed: 22271809